Martin A. Smith - 01 Sep 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Martin A. Smith
Issuer symbol
IDXX
Transactions as of
01 Sep 2021
Net transactions value
$0
Form type
4
Filing time
03 Sep 2021, 17:01:14 UTC
Previous filing
30 Aug 2021
Next filing
16 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +124 124 01 Sep 2021 Common Stock 124 $690.70 Direct F1, F3
transaction IDXX Incentive Stock Option (right-to-buy) Award +588 588 01 Sep 2021 Common Stock 588 $690.70 Direct F1, F3
transaction IDXX Restricted Stock Unit Award +74 74 01 Sep 2021 Common Stock 74 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning September 1, 2022.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2021.
F3 Not applicable.